Newron Pharmaceuticals S.p.A. (NWPHF) Financials
Stock symbol NWPHF is outdated, potentially delisted? Maybe it is available on other exchange?
NWPHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 47.0 million | 60.1 million |
| June 30, 2025 | 72.4 million | 70.5 million |
| Dec. 31, 2024 | 66.5 million | 65.0 million |
| June 30, 2024 | 26.8 million | 59.9 million |
NWPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -1.2 million | 65741 |
| June 30, 2025 | 19.6 million | 91935 |
| Dec. 31, 2024 | -9.2 million | 89554 |
| June 30, 2024 | -9.5 million | 182495 |
NWPHF Net Income
No data available :(
NWPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 33.9 million | - | 821774 |
| June 30, 2025 | 50.9 million | 21.3 million | 865137 |
| Dec. 31, 2024 | 10.2 million | 37.7 million | 845564 |
| June 30, 2024 | 13.1 million | 52.1 million | 344594 |
NWPHF Shares Outstanding
NWPHF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 18783 | 10.5 million | 3.1 million | 44610 |
| June 30, 2025 | 18269 | 3.7 million | 2.6 million | 28877 |
| Dec. 31, 2024 | 6248 | 7.5 million | 3.0 million | 62480 |
| June 30, 2024 | 7514 | 6.9 million | 5.0 million | 62263 |
NWPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 15.5 million | - |
| June 30, 2025 | 7.0 million | - |
| Dec. 31, 2024 | 50.0 million | - |
| June 30, 2024 | 3.7 million | - |
NWPHF
Price: $20
52 week price:
Earnings Per Share: -0.75 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 416.1 million